A method of treating an inflammatory or fibrotic disease in a subject is disclosed. The method comprises administering to the subject a therapeutically effective amount of an agent which down regulates an activity and/or an amount of Bcl x L and/or Bcl w and/or p21 with the proviso that the inflammatory disease is not cancer.